Hyptran
Hyptran Brand names, Hyptran Analogs
- (+/-)-Secobarbital
- Barbosec
- Bipanal
- Bipinal sodium
- DEA No. 2315
- DEA No. 2316
- Evronal
- Evronal Sodium
- Evrronal
- Hypotrol
- Hyptran
- Imesonal
- Immenoctal
- Immenox
- Meballymal
- Meballymal sodium
- Meballymalum
- Novosecobarb
- Pramil
- Quinalbarbital
- Quinalbarbitone
- Quinalbarbitone sodium
- Quinalspan
- Sebar
- Seco 8
- Secobarbital (USP)
- Secobarbital Sodium
- Secobarbital [USAN:INN]
- Secobarbital suppository dosage form
- Secobarbitale [DCIT]
- Secobarbitalum [INN-Latin]
- Secobarbitone
- Seconal
- Seconal (TN)
- Seconal Sodium
- Sedutain
- Seotal
- Sodium Secobarbital
- Sodium Seconal
- Sodium quinalbarbitone
- Somosal
- Synate
- Trisomnin
Hyptran Brand Names Mixture
- No information avaliable
Hyptran Chemical_Formula
C12H18N2O3
Hyptran RX_link
No information avaliable
Hyptran fda sheet
Hyptran msds (material safety sheet)
Hyptran Synthesis Reference
No information avaliable
Hyptran Molecular Weight
238.283 g/mol
Hyptran Melting Point
100 oC
Hyptran H2O Solubility
550 mg/L
Hyptran State
Solid
Hyptran LogP
1.879
Hyptran Dosage Forms
Capsule
Hyptran Indication
For the Short-term treatment of intractable insomnia for patients habituated to barbiturates
Hyptran Pharmacology
Secobarbital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.
Hyptran Absorption
No information avaliable
Hyptran side effects and Toxicity
No information avaliable
Hyptran Patient Information
No information avaliable
Hyptran Organisms Affected
Humans and other mammals
